Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Betaxolol
Drug ID BADD_D00263
Description A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.
Indications and Usage For the management of hypertension.
Marketing Status approved; investigational
ATC Code C07AB05; S01ED02
DrugBank ID DB00195
KEGG ID D07526
MeSH ID D015784
PubChem ID 2369
TTD Drug ID D03ROX
NDC Product Code 42806-039; 24658-700; 42806-038; 24658-701
UNII O0ZR1R6RZ2
Synonyms Betaxolol | Betaxolol Hydrochloride | Hydrochloride, Betaxolol | Kerlone | Oxodal | Kerlon | SL-75212 | SL 75212 | SL75212 | ALO-1401-02 | ALO 1401 02 | ALO140102 | Betoptic | Betoptima | Betaxolol Alcon | Alcon, Betaxolol
Chemical Information
Molecular Formula C18H29NO3
CAS Registry Number 63659-18-7
SMILES CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Mouth ulceration07.05.06.004--Not Available
Muscle spasms15.05.03.004--
Muscle twitching15.05.03.005--Not Available
Myalgia15.05.02.001--
Myasthenia gravis10.04.05.001; 17.05.04.001; 15.05.08.001--
Myocardial infarction24.04.04.009; 02.02.02.007--
Nasopharyngitis22.07.03.002; 11.01.13.002--Not Available
Nausea07.01.07.001--
Neck pain15.03.04.009--
Nervous system disorder17.02.10.001--Not Available
Nervousness19.06.02.003--Not Available
Neuralgia17.02.07.005--
Neuropathy peripheral17.09.03.003--Not Available
Nightmare19.02.03.003--Not Available
Ocular hyperaemia06.04.05.004--Not Available
Oedema14.05.06.010; 08.01.07.006--Not Available
Oliguria20.01.03.004--Not Available
Osteoarthritis15.01.04.001--Not Available
Pain08.01.08.004--
Palpitations02.11.04.012--
Panophthalmitis06.04.05.005--Not Available
Paraesthesia23.03.03.094; 17.02.06.005--
Periorbital oedema23.04.01.002; 10.01.05.010; 06.08.03.017--
Peripheral coldness24.04.03.006; 23.06.04.008; 08.01.09.010--Not Available
Peripheral ischaemia24.04.03.002--
Peyronie's disease21.12.01.002--Not Available
Pharyngitis22.07.03.004; 11.01.13.003; 07.05.07.004--
Photophobia17.17.02.006; 06.01.01.004--
Pneumonia11.01.09.003; 22.07.01.003--Not Available
Prostatitis21.09.01.001--Not Available
The 5th Page    First    Pre   5 6 7 8    Next   Last    Total 8 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene